Atomoxetine Drug Properties for Repurposing as a Candidate Alzheimer’s Disease Therapeutic Agent
阿托莫西汀的药物特性使其有望成为阿尔茨海默病治疗药物的候选药物
期刊:Brain
影响因子:11.7
doi:10.1093/brain/awaf323
Dammer, Eric B; Read, R; Luis Jimenez Macias, J; Oh, S; Hu, Z; Yin, K; Sele, N; Boon, N; Sing, A; Sloan, S; Yordanov, N Y; Maleki, N; Amiruddin, R; Moawad, A W; Gkampenis, A; Fehringer, P; Umeh, F; Chukwurah, C; Pytlarz, M; Ivory, M; Petrovic, B; Albalooshy, B; Schrickel, E; Memon, F; Cramer, J; Krycia, M; Alotaibi, A; Jakovljevic, M; Guelen, M S; Ghonim, M; Ghonim, M; Page, N; Mhana, S; Baid, U; Lohmann, P; Bakas, S; Aboian, M; Babovic-Vuksanovic, D; Moertel, C L; Shuhaiber, H H; Viskochil, D; Sidhu, A; Meade, J; Hirbe, A C; Weintraub, L; Langseth, A J; Weber, M D; Lokku, A; Hajjar, F M; Antony, R; Schiff, D; Raslan, A M; Nevel, K; Gershon, T R; Demsey, Laura L; Burch, Danielle; Lin, Evan; Quach, Diana; Podvin, Sonia; Boyarko, Ben; Levey, Allan I; Weinshenker, David; Edland, Steven; Galasko, Douglas; Jacobs, Heidi; Bang, Anne; Neil, Ashley; Silverman, James; Feldman, Howard H; Hook, Vivian
